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Exogenously expressed opsins are valuable tools for
optogenetic control of neurons in circuits. A deeper
understanding of neural function can be gained by
bringing control to endogenous neurotransmitter
receptors that mediate synaptic transmission. Here
we introduce a comprehensive optogenetic toolkit
for controlling GABAA receptor-mediated inhibition
in the brain. We developed a series of photo-
switch ligands and the complementary genetically
modified GABAA receptor subunits. By conjugating
the two components, we generated light-sensitive
versions of the entire GABAA receptor family. We
validated these light-sensitive receptors for applica-
tions across a broad range of spatial scales, from
subcellular receptor mapping to in vivo photo-
control of visual responses in the cerebral cortex.
Finally, we generated a knockin mouse in which
the ‘‘photoswitch-ready’’ version of a GABAA recep-
tor subunit genomically replaces its wild-type coun-
terpart, ensuring normal receptor expression. This
optogenetic pharmacology toolkit allows scalable
interrogation of endogenous GABAA receptor func-
tion with high spatial, temporal, and biochemical
precision.
INTRODUCTION
GABA (g-aminobutyric acid) is the main inhibitory neurotrans-
mitter in the brain, acting in counterpoint to glutamate, the
main excitatory neurotransmitter. The delicate balance between
GABAergic inhibition and glutamatergic excitation is essential
for normal sensory processing, motor pattern generation, and
cognitive function. Abnormalities in GABA-mediated inhibition
have devastating consequences, contributing to pathological
pain (Zeilhofer et al., 2012), movement disorders (Galvan and
Wichmann, 2007), epilepsy (Treiman, 2001), schizophrenia (Gui-dotti et al., 2005), and neurodevelopmental disorders (Rama-
moorthi and Lin, 2011).
GABA exerts its effects largely through ligand-gated Cl chan-
nels known as GABAA receptors (Farrant and Nusser, 2005).
GABAA receptors are heteropentamers containing two a, two
b, and one tertiary subunit. The a subunit contributes to GABA
binding and determines gating kinetics and subcellular locali-
zation of the receptor (Olsen and Sieghart, 2009; Picton and
Fisher, 2007; Rudolph andMo¨hler, 2014). There are six a subunit
isoforms expressed differentially during development (Laurie
et al., 1992) and across brain regions (Wisden et al., 1992), but
the distinct functions of individual isoforms remain elusive.
Pharmacological agents, including agonists, competitive an-
tagonists, and allosteric modulators, have been the main instru-
ments for elucidating the function of GABAA receptors. However,
these tools are limited by the low spatial and temporal precision
of drug application. Moreover, accurate manipulation of GABAA
isoforms has been hindered by the lack of subtype-specific
agonists or antagonists for the GABA-binding site. There are
subtype-selective allosteric modulators for the benzodiaze-
pine-binding site, but they have limited specificity and/or low ef-
ficacy (Rudolph and Mo¨hler, 2014). Gene knockout technology
provides an alternative strategy for deducing the function of
GABAA isoforms, but removal of one a subunit can lead to
compensatory changes in the expression of other receptors
and ion channels (Kralic et al., 2002; Ponomarev et al., 2006;
Brickley et al., 2001).
For these reasons, we have developed an optogenetic phar-
macology strategy that enables isoform-specific photo-control
of the entire GABAA receptor family and, by extension, all
GABAA-mediated inhibition in the brain. We show that photo-
control can be implemented at all levels, from investigating sub-
cellular receptor distribution to regulating visual cortical activity
in vivo. Finally, we introduce a transgenic mouse that allows,
for the first time, photo-control of an endogenous neurotrans-
mitter receptor. Instead of controlling an exogenous optogenetic
tool that overpowers the native electrophysiology of neurons
(e.g., NpHR or Arch; Zhang et al., 2011), our approach allows
direct manipulation of the brain’s own GABAA receptors, a
powerful strategy for understanding the roles they play in health
and disease.Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 879
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Figure 1. Optogenetic Pharmacology Toolkit for the GABAA Receptor Family
(A) The operating principle of LiGABAR. A PTL is conjugated onto the a subunit near the GABA-binding site. Isomerizing the PTL with two different wavelengths of
light prevents or allows GABA binding, thereby controlling whether the receptor can be activated to open the chloride-conducting channel.
(B) PTLs consist of a cysteine-reactive maleimide group, a photosensitive azobenzene core, and a GABA-site ligand (blue; linked to azobenzene directly or via a
short spacer).
(C) Photo-control of a representative LiGABAR (PAG-1C conjugated a1T125C, coexpressed with the wild-type b2 and g2S). Currents were elicited by 30 mM
GABA in 380-nm (violet) or 500-nm (green) light.
(D) a1-LiGABAR functions like thewild-type receptor in 380-nm light and is strongly inhibited in 500-nm light. Data points aremean ± SEM. Dose-response curves
are fits to the Hill equation. Black: wild-type, seven cells; violet: LiGABAR/380 nm, six cells; green: LiGABAR/500 nm, four cells.
(E) Quantification of LiGABAR photosensitivity for each a isoform. Currents were elicited by GABA at EC50 of the wild-type receptors (see [GABA]test values in
Figure S2). Photosensitivity is described as the percent decrease of peak current by photo-antagonism. Data are plotted as mean ± SEM (n = 4–6).
(F) The PTL attachment site for each a isoform. The sequences of loop E in rat a1–a6 subunits are aligned. Sites for cysteine substitution are shown in bold orange.
Recordings for (C)–(E) were carried out in HEK cells held at 70 mV. See also Figures S1–S3.RESULTS
The Light-Regulated GABAA Receptor Toolkit
The GABAA receptor has two GABA-binding sites, each at the
interface of a and b subunits (Figure 1A). Light-regulated
GABAA receptor (LiGABAR) is generated by conjugating a pho-
toswitchable tethered ligand (PTL) onto a cysteine genetically
engineered into the a subunit near the GABA-binding site. The
PTL molecule has three chemical modules (Figure 1B): a
cysteine-reactive maleimide group (for receptor conjugation),
an azobenzene core (for photoswitching), and a GABA-site
ligand (for competitive antagonism). The azobenzene adopts
an extended trans configuration in darkness and a twisted cis
configuration in 360- to 400-nm light. The cis isomer slowly
reverts to the trans form in darkness, but this process can be
accelerated with 460- to 560-nm light. Hence, photo-control is
bidirectional. Depending on where the PTL is attached, either880 Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc.the cis or the trans isomer antagonizes the receptor, and photo-
switching to the alternative configuration alleviates antagonism
(Figure 1A).
We previously developed PTLs with muscimol as the parent
ligand (linked to azobenzene via N-acylation; Lin et al., 2014).
Although these compounds do impart light sensitivity on
GABAA receptors, their low efficacy limited the magnitude of
photoswitching in vitro and their poor solubility (<50 mM)
excluded their use in vivo. To improve efficacy, we made new
PTLs with either GABA or its guanidinium analogs as the ligand
(Figure 1B; Figure S1). We expected that these PTLs would be
antagonists, like other ester or amide derivatives of GABA (Mat-
suzaki et al., 2010). The diffuse positive charge of the guanidi-
nium group may enhance ionic, hydrogen-bond, and/or cation-
p interactions with the receptor (Bergmann et al., 2013; Miller
and Aricescu, 2014), and protonation of amino/guanidine groups
at neutral pH should enhance water solubility of the PTLs.
The new PTLs were conjugated onto a series of cysteine mu-
tants of a1 (Figure S1), coexpressed with wild-type b2 and g2 in
HEK293 cells. The optimal combination of PTL and cysteine
mutant was PAG-1C (Figure 1B) and a1T125C (Figures 1C–1F;
Figure S1). As expected, the GABA-elicited current was strongly
reduced in 500-nm light (trans-PTL) and completely restored
in 380-nm light (cis-PTL; Figure 1C). Cis-to-trans photoisomeri-
zation reduced the response to half-saturating GABA by
78% ± 2% (10 mM, n = 6; Figure 1E) and to saturating GABA
by 57% ± 2% (300 mM, n = 6). Dose-response curves showed
that the EC50 (half-maximal effective concentration) increased
from 15.3 ± 6.0 mM (n = 6) to 583 ± 139 mM (n = 4) when the
PTL was switched from cis to trans (Figure 1D), consistent with
the induction of competitive antagonism. Receptor activation
was indistinguishable from wild-type with the PTL in the cis
configuration (wild-type EC50 = 9.5 ± 2.3 mM, n = 7, p > 0.1,
two-tailed t test). Taken together, the discovery of PAG-1C for
a1-LiGABAR validates the PTL design and establishes effective
photo-control of this receptor isoform.
We next applied the PTL strategy to all other a isoforms (a2–
a6) to obtain the complete LiGABAR toolkit. We paired cysteine
mutants of a subunits (focusing on loop E, where a1T125C is
located) with a library of PTLs, and the resulting LiGABARs
were evaluated in HEK293 cells. These PTLs varied in their li-
gands (GABA, guanidinylated GABA, and guanidine acetic
acid; Figure S1) and spacer lengths between the ligand and
the azobenzene. For each isoform, we selected the best PTL/
mutant pair (Figures 1E and 1F; Figure S2) based on two criteria:
(1) GABA-elicited currents are robustly photo-controlled (prefer-
ably R50% photo-antagonism at EC50), and (2) receptor func-
tion is unaffected by cysteine mutation and PTL conjugation.
Notably, we found a homologous mutation site that enables
the reversed polarity of photo-control (i.e., antagonizing the re-
ceptor by cis-PTL). When a longer PTL (e.g., PAG-2A, PAG-2B,
or PAG-3C in Figure 1B) is conjugated onto this site, GABA-eli-
cited current is reduced in 380-nm light by 45%–70% and is fully
restored in 500-nm light (Figures 1E and 1F, a2–a6; 48% ± 5%
reduction by PAG-3C on a1T121C, n = 3). Interestingly, some
of the mutants enable either a cis or transmode of photo-antag-
onism when conjugated with a longer or a shorter PTL, respec-
tively (e.g., a2 and a5 LiGABARs in Figure 1E). This dual option
adds flexibility in whether or not the receptor will be turned off
in the ground state (i.e., in darkness), an important consideration
for applications in neural circuits.
Even though all of the receptors have a cysteine point muta-
tion, this change appears to have minimal effects on receptor
function, unless the PTL is conjugated and switched to the
antagonizing configuration. None of the cysteine mutations, by
themselves, alter receptor activation (Figure S2). Moreover,
neither cysteine substitution nor PTL conjugation affects the
characteristic properties of the parent receptor, such as allo-
steric modulation at the benzodiazepine site or anion perme-
ability of the channel (Figure S2). Hence, LiGABARs function as
their normal receptor counterparts until the moment they are
photo-antagonized by a conjugated PTL.
Wild-type GABAA receptors, which lack a properly positioned
cysteine near the GABA-binding pocket, remain insensitive to
light after PTL treatment (Figures S1 and S3). Moreover, PTLtreatment does not confer light sensitivity onto GABAB recep-
tors, glutamate receptors, or voltage-gated Na+ and K+ channels
(Figure S3), indicating there are few, if any, acute off-target ef-
fects on proteins that govern the electrophysiology of a neuron.
Subcellular Mapping of GABAA Receptor Isoforms with
Optogenetic Pharmacology
Isoforms of GABAA receptors can be immunolocalized in distinct
compartments of a dissociated neuron (Bru¨nig et al., 2002),
but subcellular localization can be problematic in intact neural
tissue with intertwined cells. Moreover, antibody labeling cannot
differentiate functional receptors from those that might be
silent. Functional GABAA receptors can bemappedwith pinpoint
accuracy via two-photon photolysis of ‘‘caged GABA’’ (Matsu-
zaki et al., 2010), but this method cannot differentiate receptor
isoforms. Optogenetic pharmacology with LiGABARs can over-
come these limitations by allowing discrimination between func-
tional receptor isoforms.
To validate this idea, wemapped the functional distributions of
a1- and a5-LiGABARs in hippocampal CA1 pyramidal neurons.
The cysteine mutant of the a1 or a5 subunit (a1T125C or
a5E125C) was virally coexpressed with GFP in a rat hippocam-
pal slice. The transduced slice was then treated with PTL
(PAG-1C), and fluorescent neurons were selected for whole-
cell voltage-clamp recording. We monitored responses to unc-
aged GABA when LiGABARs were either antagonized (by
540 nm) or relieved from antagonism (by 390 nm). By measuring
the ratio of responses in these two conditions, we reveal the
contribution of a particular a isoform to the uncaging response
and control for potential sources of variability. Other control ex-
periments demonstrate that the two-photon uncaging response
was unaltered by the conditioning light for receptor photo-con-
trol (Figure S4A; validated in the absence of the PTL), and that
the two-photon light used for uncaging did not affect the state
of the LiGABAR (Figure S4B).
We first obtained a low-resolution view of where a1- and a5-Li-
GABARs are present (Figures 2A and 2B). Two locations were
examined: one at or close to the soma (proximal site), and one
on the primary apical dendrite (70–80 mm from the soma; distal
site). Each uncaging site spanned 7–10 mm. In cells expressing
a1-LiGABAR, photoswitching (defined as the fraction of current
antagonized by light) was more profound proximally than
distally, with the effect decreasing from 0.47 ± 0.02 at the prox-
imal site to 0.11 ± 0.07 at the distal site (p < 0.05, n = 5, paired
t test; Figures 2A and 2C). In contrast, when a5-LiGABAR
was expressed, photoswitching was not significantly different
between the two sites (0.33 ± 0.09 at the proximal site and
0.50 ± 0.06 at the distal site; p > 0.1, n = 5, paired t test; Figures
2B and 2C). These results suggest that functionally active a1-
and a5-GABAA receptors are differentially distributed, with a1
concentrated near the soma and a5 extending to more distal
locations along the apical dendrite.
We next obtained a higher-resolution map of dendritic a1- and
a5-LiGABARswith smaller, more closely spaced uncaging spots
(2.5 mm, 5 mm apart; Figures 2D and 2E). We found that the
amplitude of GABA-elicited current varied between these spots
in neurons expressing either a1 or a5. Independent of this, how-
ever, there was a striking difference in the spatial pattern ofNeuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 881
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Figure 2. Mapping Subcellular Distributions
of Specific GABAA Isoforms
(A–C) Low-resolution mapping of a1- and a5-Li-
GABARs (both antagonized by trans-PAG-1C) in
CA1 pyramidal neurons.
(A) Left: image of a neuron (filled with Alexa Fluor
594) expressing a1-LiGABAR. Red boxes indicate
the proximal (prox) and distal (dist) locations for
two-photon RuBi-GABA uncaging (800 nm, 5–
10ms). Right: currents elicited by uncaging at 2min
after a 5-s flash of 390-nm (violet) or 540-nm (green)
light. Note that photoswitching is diminished at the
distal site.
(B) Measurements from a neuron expressing a5-
LiGABAR. Note that photoswitching remains
prominent at the distal site. Scale bars in (A) and (B)
represent 10 mm (images) and 20 pA, 200 ms
(traces).
(C) Group data of photoswitching at proximal and
distal sites (five cells for each isoform).
(D–G) Higher-resolution mapping of a1- and a5-
LiGABARs along the apical dendrites.
(D) Top: image of soma and proximal dendrite from
a neuron expressing a1-LiGABAR. RuBi-GABAwas
uncaged at seven sites (each spanning 2–3 mm)
along the dendrite. Bottom: currents elicited at
each site after 390-nm (violet) or 540-nm (green)
conditioning flashes.
(E) Measurements from a neuron expressing a5-
LiGABAR. Scale bars in (D) and (E) represent 8 mm
(images) and 50 pA, 500 ms (traces).
(F) Photoswitching (mean ± SEM) quantified for
each uncaging site shown in (D) and (E).
(G) Photoswitching values pooled from 22 and 18
uncaging sites in neurons expressing a1- and a5-
LiGABAR, respectively (five cells each).
(H and I) Probing the localization of a1-LiGABAR to
inhibitory synapses. Experiments were carried out
in cultured hippocampal neurons coexpressing
a1-LiGABAR andGFP-fused gephyrin intrabody. Two-photon uncaging of RuBi-GABAwas performed at single-pixel resolution, either at GFP-positive puncta (p)
or at adjacent GFP-negative locations (np).
(H) Representative images and recording traces. Cells were filled with Alexa Fluor 594 (red). GFP-positive puncta (yellow) indicate the location of inhibitory
synapses. Scale bars represent 2 mm (images) and 2 pA, 100 ms (traces).
(I) Group data (from five cells) showing that photoswitching of a1-LiGABAR is detectable only at GFP-positive puncta.
Neurons were held at 0mV. Traces are averages from three to five trials. Photoswitching is calculated as the fraction of current photo-antagonized. For (C) and (I),
individual measurements (average of each site) are plotted as open symbols, and the mean values for each group are represented by filled symbols. Error bars
indicate SEM.photoswitching between these two isoforms (Figures 2D–2G).
Photosensitivity appeared to be localized to ‘‘hotspots’’ for a1
(Figures 2D and 2F) but distributed evenly along the dendrite
for a5 (Figures 2E and 2F). Group data show higher spatial vari-
ability of photoswitching for neurons expressing a1-LiGABAR
than for those expressing a5-LiGABAR, consistent with clus-
tering of a1-containing receptors (coefficient of variation: 0.59
for a1 versus 0.18 for a5, p < 0.05, Levene’s test, n = 22 and
18 uncaging sites from five and six cells, respectively; Figure 2G).
Immunolabeling studies showed that the a1 isoform is
concentrated at inhibitory synapses (Bru¨nig et al., 2002; Kasugai
et al., 2010). To verify that the photoswitching hotspots of a1-
LiGABAR represent clusters of functional receptors at synapses,
we targeted inhibitory synapses using a genetically encoded
fluorescent intrabody for gephyrin (a scaffolding protein that
tethers GABAA receptors at synapses; Gross et al., 2013). Neu-882 Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc.rons expressing the gephyrin intrabody exhibit fluorescent
puncta at postsynaptic sites. We found significant photoswitch-
ing of responses only when GABA was uncaged at gephyrin
puncta (0.32 ± 0.07 at puncta versus 0.01 ± 0.03 at 4 mm
outside of puncta, n = 7 and 5 sites from five cells, respectively,
p < 0.001, paired t test; Figures 2H and 2I). Hence, by combining
LiGABAR photo-control with two-photon uncaging, one can
generate a functional map of a specific GABAA isoform on a
neuron, resolved at the level of individual synaptic contacts.
Photo-Control of Synaptic Inhibition with LiGABARs
We next tested whether LiGABARs can enable photo-control
of inhibitory postsynaptic currents (IPSCs). Mutant a subunits
were exogenously expressed by viral transduction in mouse
cerebral cortex. Brain slices were treated with PTLs to generate
LiGABARs. Monosynaptic IPSCs were evoked by electrical
CA
B
Figure 3. LiGABARs Enable Photo-Control of Synaptic and Tonic
Inhibition
(A) Photo-control of inhibitory postsynaptic currents (IPSCs) by a trans-
antagonist (PAG-1C, conjugated to a1T125C).
(B) Photo-control of IPSCs by a cis-antagonist (PAG-2A, conjugated to
a5E125C). Light intensity was 1 mW/cm2.
Left: representative traces. Right: changes in peak IPSC amplitudes in dark-
ness (white), 380-nm light (violet), and 500-nm light (green). Data are plotted as
mean ± SEM. Note the opposite polarity of photo-control and the different
default level of IPSCs (in darkness) in (A) and (B). See also Figure S5.
(C) Photo-control of tonic currents by a trans-antagonist (PAG-1C, conjugated
to a5E125C). Light intensity was 4.5 mW/mm2 for 390 nm and 28 mW/mm2 for
540 nm. Current levels were sustained after light flashes due to the bistability of
LiGABAR (see Figure 4C). Photo-control was abolished after all of the GABAA
receptors (including a5-LiGABAR) were blocked by picrotoxin (100 mM).
Recordings were carried out in cortical (A and B) or hippocampal (C) pyramidal
neurons held at 0 mV.stimulation of local inhibitory inputs while blocking excitatory
glutamate receptors.
When we employed a LiGABAR that exhibits trans-antago-
nism (PAG-1C on a1), we found that IPSC amplitude was
63% ± 3% smaller in 500-nm light than in 380-nm light (p <
0.05, n = 6, paired t test; Figure 3A). When we used a LiGABAR
that exhibits cis-antagonism (PAG-2A on a5), we observed the
opposite effect: IPSC amplitude was 52% ± 2% smaller in
380-nm light than in 500-nm light (p < 0.05, n = 6, paired t test;
Figure 3B). Hence, synaptic inhibition can be photo-controlled
with either polarity.
In principle, the amplitude of IPSCs can be changed by altering
presynaptic GABA release or postsynaptic GABAA receptors. To
verify that our observed effects are entirely postsynaptic, we
compared the paired-pulse ratio (PPR) at the two photoswitch-
ing wavelengths. Changes in PPR would reflect changes in pre-synaptic release probability (Zucker and Regehr, 2002). We
found that the PPR was the same under 380- and 500-nm illumi-
nation (0.9 ± 0.1 versus 0.9 ± 0.1, p > 0.05, n = 11, paired t test),
indicating that photoswitching was entirely a postsynaptic
phenomenon.
Extrasynaptic GABAA receptors mediate tonic inhibition, im-
portant for setting the tone of excitability in the brain (Farrant
and Nusser, 2005). To test whether LiGABARs enable photo-
control of tonic inhibition, we recorded from hippocampal
pyramidal neurons expressing a5-LiGABAR (conjugated with
PAG-1C). To magnify GABA-mediated currents, neurons were
clamped at 0 mV, far from the ECl (chloride reversal potential;
70 mV), and a small volume of artificial cerebrospinal fluid
(aCSF; 30 ml) was recirculated to avoid washout of extracel-
lular GABA. Under these conditions, a brief flash of 390-nm light
caused an outward current increase of 52 ± 13 pA (n = 5) that was
reversed by 540-nm light (Figure 3C). The effect of light was abol-
ished after applying picrotoxin (100 mM), confirming that it was
mediated by GABAA receptors.
Our results suggest that viral expression of the LiGABAR
mutant alone, in the absence of the photoswitch, did not signif-
icantly alter synaptic properties. We compared the ratio of excit-
atory and inhibitory synaptic currents (E/I ratio) in a1T125C-ex-
pressing versus nonexpressing neurons in cortical slices. The
E/I ratio was the same in mutant-expressing neurons and in con-
trol neurons, and there was no difference in the kinetics of IPSCs
between the two groups (Figure S5). Taken together, LiGABARs
can be exogenously introduced into brain tissue without chang-
ing the balance between synaptic excitation and inhibition.
Kinetics of LiGABAR Photo-Control
Optogenetic tools allow rapid manipulations of neuronal activ-
ities with temporal precision. To test the speed of LiGABAR
photo-control, we measured the minimal illumination time
required for full IPSC photoswitching in CA1 pyramidal neurons
with a1-LiGABAR. A flash of 540-nm (28 mW/mm2) or 390-nm
(4.5 mW/mm2) light was applied 100 ms prior to presynaptic
stimulation to antagonize or restore the receptor, respectively.
We first fully antagonized LiGABAR with a fixed duration of
540-nm light (500 ms) and restored receptor activity with various
durations of 390-nm light (ranging from 10 to 500 ms; Figure 4A).
Photoswitching (relief of antagonism) increased with increasing
duration of 390-nm light, and approached maximal (>95%)
with a 100-ms flash. We next repeated the experiment with
different durations of 540-nm light (and fixed 390-nm flashes;
Figure 4A). In this case, photoswitching (induction of antago-
nism) approached maximal with a 200-ms flash of 540-nm light.
We next tested whether rapid control of synaptic inhibition
could change the spike output of a neuron in response to
synaptic stimulation. Current-clamp recordings were carried
out in CA1 pyramidal neurons expressing a1-LiGABAR.We elec-
trically stimulated Shaffer collaterals, recruiting overlapping
excitatory and inhibitory synaptic inputs that have opposite
effects on spiking. Each stimulus elicited a single spike when
LiGABAR was photo-antagonized. The spike was eliminated
when LiGABAR was relieved from antagonism. The spiking
response could be gated with a flash of light as brief as
100 ms, delivered immediately before the presynaptic stimulusNeuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 883
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Figure 4. Kinetics of LiGABAR Photo-Control
(A) Violet: illumination time required for restoring Li-
GABAR from antagonism. Pairs of IPSCs were re-
corded, one measured with a fixed duration of
540 nm (500 ms) and the other with a variable
duration of 390 nm. Green: illumination time required
for imposing LiGABAR antagonism. The same
measurements were made with a fixed duration of
390 nm (500 ms) and variable durations of 540 nm.
Conditioning flashes were delivered 100 ms prior to
synaptic stimulation. Inset: representative photo-
sensitive IPSC component (IPSC390 IPSC500) from
the same neuron receiving different durations of
conditioning light. Scale bars represent 50 pA,
500 ms. Fractional photoswitching was defined as
the normalized photosensitive IPSC amplitude.
Group data of fractional photoswitching (symbols;
mean ± SEM) versus flash duration were fit with
single exponentials (curves). n = 2–4 cells.
(B) Photo-control of synaptically stimulated action
potential firing with a brief flash of light. With the
neuron at rest (around 70 mV; current clamp), a
brief flash of conditioning light (colored squares) was
applied 100 ms prior to Schaffer-collateral stimula-
tion (triangles). A 100-ms flash of each conditioning
light was sufficient for photo-controlling spike gen-
eration. Scale bars represent 20 mV, 1 s. Green:
540 nm; violet: 390 nm.
(C) Bistability of LiGABAR. Prior to illumination,
LiGABARwas antagonized by the trans-PTL in darkness (a). The amplitude of IPSCs increased upon the illumination of 380 nm (b), which then decreased slowly in
darkness after the conditioning light was turned off (c). The amplitude of IPSCs reduced to the initial level upon the illumination of 500 nm (d), which remained
steady in darkness thereafter. The time course of IPSC decrease in darkness (post 380 nm) is fitted with a single exponential decay (red curve; t = 30 ± 6 min) to
depict the thermal relaxation of the cis-PTL. Scale bars represent 50 pA, 50 ms.
Recordings were carried out in cortical or hippocampal pyramidal neurons expressing a1-LiGABAR.(Figure 4B). Collectively, our results (Figures 4A and 4B) sug-
gest that inhibition can be photo-controlled at a timescale of
100–200 ms. Because the speed of photo-control is largely
determined by light intensity, LiGABAR manipulation may be
accelerated further with a brighter light source.
LiGABARs can also be used as a bistable switch. To illustrate
this feature, we monitored the IPSC amplitude after transient
conditioning with 380- or 500-nm light (Figure 4C). The IPSC
amplitude was elevated by 380-nm light, and slowly decreased
upon returning to darkness with a time constant of 30 ± 6 min
(95% confidence bounds: 26 ± 4 min and 38 ± 8 min; n = 4).
Exposure to 500-nm light quickly reduced the IPSC back to
the initial amplitude, where it remained steady over 10 min.
Hence, LiGABAR can be stably toggled between antagonized
and antagonism-relieved states with brief flashes of conditioning
light. This feature minimizes phototoxicity and enables the use of
other optical manipulations in the same experiment (e.g., GABA
uncaging; Figure 2).
Spatial Reach of LiGABAR Photo-Control in the Brain
Before implementing LiGABAR in vivo, we needed to define
how far the PTL and the light can penetrate through brain tissue
to enable photo-control. We first determined how deep into
the cerebral cortex the PTL can penetrate to form LiGABAR
(Figures 5A–5C). To evaluate this parameter, we first expressed
the mutant a subunit by stereotactically injecting a virus (en-
coding a1T125C and eGFP) into mouse visual cortex. After884 Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc.10–14 days, the mouse was anesthetized, and a craniotomy
was performed to expose the cortex where neurons expressed
the mutant receptor. Following the subsequent duratomy, a
droplet of aCSF containing the PTL (250 mM PAG-1C) was
applied onto the exposed brain surface (Figure 5A).
After 1 hr of treatment, we prepared cortical slices and re-
corded from GFP-positive neurons at various depths beneath
the craniotomy region. The degree of IPSC photoswitching
was assessed as an index of LiGABAR formation. We found
that the degree of IPSC photoswitching declined with the depth
from the pia, decreasing from 40% near the surface to0% at
400 mm away from the surface (Figure 5B). This decline in IPSC
photosensitivity could be fit with a single exponential function
with a depth constant of 371 mm (95% confidence bounds: 239
and 824 mm; n = 15 cells from three mice; Figure 5C).
We next used a brain slice as a surrogate for intact brain tissue
to evaluate how far the light can penetrate to photo-control
LiGABAR (Figures 5D–5F). We prepared acute cortical slices
from virally transduced mice, and incubated the slices in PTL-
containing aCSF to allow uniform receptor conjugation. In each
neuron, we measured the ratio of IPSC photoswitching under
two different illumination conditions: first, with light projected
directly into the slice axially from the pia surface and, second,
with light projected directly onto the slice in cross-section (Fig-
ure 5D). Axial illumination should photo-control LiGABAR
maximally near the pia surface, where light intensity is high-
est. Cross-sectional illumination should photo-control LiGABAR
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Figure 5. Accessibility of LiGABAR Photo-Control from the Surface
of the Brain
(A) Strategy for measuring the penetration depth of a PTL into an intact brain.
(B) Map of the depth dependence of IPSC photoswitching. Each point in-
dicates the location of a recorded cell in cortical layers (L1–L5), with the
magnitude of IPSC photoswitching color coded.
(C) Depth-dependent decrease in IPSC photoswitching (n = 15 cells). The data
were normalized and fit with an exponential decay to calculate the depth
constant (l) of PTL penetration from the brain surface.
(D) Strategy for estimating the penetration depth of light into the brain. The
axial light mimicked the in vivo illumination (with light penetrating into the brain
from the pia surface). The cross-sectional light photo-controlled LiGABARs
regardless of the cell position, providing a scale factor for estimating the
effectiveness of the axial light.
(E) Depth dependence of IPSC photoswitching, with either axial or cross-
sectional illumination.
(F) Depth-dependent decrease in IPSC photoswitching. The data (ratio of axial
versus cross-sectional photoswitching from 12 cells) were normalized and fit
with an exponential decay to calculate the depth constant of photoswitching
from the brain surface.
The virus used in these experiments encodes mutant a1T125C and eGFP.
PTL, PAG-1C.uniformly, with variability attributable to other factors, such
as differences in the expression of the mutant subunit. Hence,
the ratio of IPSC photoswitching by axial versus cross-sectional
illumination reflects the efficiency of LiGABAR photo-control,
calibrating for other factors that could cause cell-to-cell varia-tion. We found that IPSC photoswitching by axial illumination
decreased from 41% near the pia surface to 11% at
400 mm from the surface (Figure 5E). The depth-dependent
decrease of photoswitching ratio (axial versus cross-sectional)
could be fit with a single exponential function with a depth
constant of 352 mm (95% confidence bounds: 255 and
568 mm; n = 12 cells from three mice; Figure 5F). These experi-
ments utilized an unfocused light source for axial illumination,
which emitted at 15 mW/cm2 for both wavelengths of light. A
brighter or more focused light source, or an implanted optrode
system, should allow an even deeper photo-control.
Taken together, these experiments suggest that both the PTL
and the light can effectively reach as deep as 350 mm from the
brain surface, extending through layer 2/3 of mouse cerebral
cortex.
Photo-Control of Cortical Visual Responses In Vivo
Once we established that both the PTL and the light can pene-
trate into brain tissue to control inhibition at a sufficient depth,
we tested whether photo-control is effective in vivo. Specifically,
we asked whether photo-control of LiGABAR could alter infor-
mation processing in the primary visual cortex (V1) of a mouse
as it is responding to a visual stimulus (Figure 6). The LiGABAR
mutant was virally introduced into mice 2 weeks before the ex-
periments. After the mouse underwent anesthesia, craniotomy,
and PTL treatment, we made extracellular loose-patch record-
ings from LiGABAR-expressing, parvalbumin-positive (PV+) in-
terneurons in layer 2/3 (Figures 6A and 6B). We first confirmed
that the visual stimulus, a 100% contrast drifting square grating,
evoked spikes in the recorded neurons. To toggle LiGABAR be-
tween the antagonized and nonantagonized states, we delivered
a full-field spot of conditioning light (390 or 470 nm) into the
cortex through a microscope objective. Because LiGABAR is bi-
stable (Figure 4C), a brief illumination of conditioning light (10 s)
was sufficient to switch the receptor state for several minutes.
This provided a time window for any spurious response to the
conditioning light to decay before the onset of the visual
stimulus.
We found that the pattern of spiking in PV+ neurons, during the
visual response, changed from burst firing after conditioning with
470-nm light (antagonism induced) to sustained firing after con-
ditioning with 390-nm light (antagonism relieved) (Figure 6C).
Moreover, the average increase in spike rate during the visual
stimulus was larger when LiGABAR was antagonized. Changes
in spike rate evoked by the visual stimulus could be modulated
up and down repeatedly by switching the conditioning light
back and forth (n = 7 cells from four mice, p < 0.05, one-way
ANOVA; Figure 6D). Control experiments showed that neither
the mutant alone nor the PTL alone enabled photo-control of vi-
sual responses (mutant alone, n = 6 cells from twomice, p > 0.05,
one-way ANOVA; PTL alone, n = 9 cells from two mice, p > 0.05,
one-way ANOVA; Figure 6D). Taken together, these results show
that LiGABAR can be introduced into a mouse brain for in vivo
photo-control. Furthermore, our findings support the notion
that GABAergic inhibition in PV+ neurons plays a role in informa-
tion processing in the visual cortex, such as setting the gain and
determining the temporal dynamics of the visual response (Katz-
ner et al., 2011).Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 885
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Figure 6. In Vivo Photo-Control of Visual Re-
sponses in Mouse Cortex
(A) Schematic illustration of the experimental pro-
cedures.
(B) Two-photon image of a recorded PV+ neuron.
The cell was identified by the coexpression of
tdTomato (red, marker of PV+ cells) and eGFP
(green, marker of LiGABAR expression).
(C) Experimental sequence. The raster plots and
peristimulus time histograms show the spike ac-
tivity of a PV+ neuron before any conditioning
illumination (black) and after a 10-s exposure to
either 390-nm (violet) or 470-nm (green) light.
(D) Summary of visually evoked spike activities in
PV+ neurons (circles), showing higher firing rates
when LiGABAR was antagonized (dark and
470 nm) than when it was relieved from antago-
nism (390 nm). n = 7 cells from four mice. Control
experiments with PTL treatment alone (squares;
n = 6 cells from two mice) or viral injection alone
(triangles; n = 9 cells from two mice) show no sig-
nificant difference in spike activities after exposure
to 390-nm versus to 470-nm light. Data are plotted
as mean ± SEM.A Knockin Mouse for Optical Control of Endogenous
a1-GABAA Receptors
Our results suggest that in cortical pyramidal neurons, overex-
pression of a mutant a subunit causes no significant changes
in IPSC kinetics or E/I ratio (Figure S5). However, unadulterated
expression in all neurons can only be assured by replacing
the gene encoding the wild-type a subunit with its mutant
counterpart.
To bring about exact genomic substitution, we generated a
knockin mouse in which a single point mutation (T125C) was
introduced into the gene of the a1 subunit through homologous
recombination (Figure S6). We named this knockin the a1-GA-
BAA photoswitch-ready mutant (PhoRM) mouse. Immunohisto-
chemical analysis confirmed that the expression pattern of the
mutant a1 was identical to that of the wild-type. Immunolabeling
profiles through tissue slices from cerebral cortex, hippocam-
pus, and cerebellum (Figures 7A–7F) were the same for the
a1-GABAA PhoRM mouse as for the wild-type.
Functionally, we examined the expression of a1T125C by
measuring IPSC photoswitching in PAG-1C-treated brain slices.
We compared photoswitching in neuronal cell types that differ in
the relative abundance of a1 with respect to other a isoforms
(Figures 7G and 7H). We used cell types thought to express
only the a1 isoform (cerebellar molecular layer interneurons
[MLIs] and Purkinje cells [PCs]; Eyre et al., 2012; Fritschy et al.,
2006), a cell type that expresses a1 along with other isoforms
(pyramidal neurons in layer 5 of cerebral cortex [L5 PYNs]; Ruano886 Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc.et al., 1997), and a cell type devoid of a1
(cerebellar Golgi cells [GoCs]; Fritschy
and Mohler, 1995). Photoswitching was
the strongest in MLIs and PCs (51% ±
2% and 50% ± 2%, n = 7 and 6 cells
from two and threemice, respectively), in-
termediate in L5 PYNs (30% ± 2%, n = 6
cells from two mice), and nonexistent in GoCs (2% ± 3%, n =
5 cells from three mice). Hence, the degree of photoswitching
is correlated with the relative abundance of a1 in a neuron.
Photo-Control of Sensory Responses and g Oscillations
in the a1-GABAA PhoRM Mouse
Understanding the role of inhibition in the cortex has often relied
on nonspecific blockers or antagonists of GABAA receptors. The
a1-GABAA PhoRMmouse provides the unprecedented opportu-
nity to selectively and reversibly remove a particular endogenous
receptor from a functional neural circuit both in vitro and in vivo.
We used a multielectrode probe to record extracellular spiking
activity in neurons in the visual cortex of the awake a1-GABAA
PhoRM mouse. We applied the PTL by intracranial infusion
through a micropipette inserted 275 mm into the cortex (Fig-
ure 8A), an alternative approach to topical application on the
brain surface.
We examined the response of neurons to a visual stimulus
train that consisted of 10 full-contrast checkerboard images.
We applied brief conditioning flashes to switch a1-LiGABAR
5 s before each episode of the stimulus train. In many neurons
(15/43 cells in three PTL-treated mice, p < 0.05, Friedman test
over episodes), conditioning flashes that either induced or
relieved antagonism reliably changed visually evoked spiking ac-
tivity. Owing to its inhomogeneous distribution pattern in the
brain (Figure 7; Fritschy and Mohler, 1995), we surmised that
photo-controlling a1-LiGABAR might result in heterogeneous
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Figure 7. Characterizations of the a1-GABAA PhoRM Knockin
Mouse
(A–C) Fluorescent images of antibody labeling showing the expression pattern
of the a1 subunit in the wild-type and homozygous a1-GABAA photoswitch-
ready mutant (PhoRM) mice in visual cortex (A), hippocampus (B), and cere-
bellum (C). DG, dentate gyrus; IB, inner blade; OB, outer blade; GCL, granule
cell layer; ML, molecular layer; PCL, Purkinje cell layer.
(D–F) Quantification of a1 expression in different brain regions. Fluorescence
intensity (F. I.; in arbitrary unit) was measured along the yellow dashed arrows
in (A)–(C), showing similar expression patterns between the wild-type and the
a1-GABAA PhoRM mice in all of the three brain regions analyzed. In each
genotype, the profiles were obtained from two or three sections in eachmouse
(two wild-type and three knockin mice).
(G) Representative recording traces from a cerebellar molecular layer inter-
neuron and a Golgi cell of the a1-GABAA PhoRM mouse, showing differential
photo-control of IPSCs in these cell types.
(H) Scatterplots summarizing the magnitude of IPSC photoswitching in
different types of neurons. CB, cerebellum; GoC, Golgi cell; MLI, molecular
layer interneuron; PC, Purkinje cell; PYN, pyramidal neuron.
Group data are presented as mean ± SEM. See also Figure S6.effects on cortical neurons. Indeed, some neurons showed a sig-
nificant increase in firing rate after photo-antagonism (top of Fig-
ures 8B and 8C), whereas other neurons showed a significant
decrease (bottom of Figures 8B and 8C). Photoswitching
occurred in a larger fraction of fast-spiking neurons (FS cells;
12/28) than regular spiking neurons (RSs; 3/15) (Figure 8D; see
classification of FS and RS cells in Figure S7). In control miceinfused with vehicle alone, only 1/28 FS cells and 1/16 RS cells
exhibited photosensitivity (2/44 cells in twomice, p < 0.05, Fried-
man test over episodes), confirming that spike modulation was
specifically a consequence of LiGABAR photo-control.
FS cells have been identified as mostly PV+ interneurons
(Avermann et al., 2012), which express a high level of a1-contain-
ing receptors (Hu et al., 2014), whereas RS cells are largely pyra-
midal neurons, which expressmultiple a isoforms (Bosman et al.,
2002). The bimodal effect of light is consistent with the inhibitory
microcircuit of the cortex, which includes an extensive network
of interneuron-interneuron synaptic connections. Hence, spike
rate in an interneuron will tend to decrease when its own
GABAA receptors are more active, and increase when GABAA
receptors on presynaptic interneurons are more active. Under-
standing when and where direct inhibition or disinhibition domi-
nates in the circuit is an important question that LiGABAR will
help to answer.
g oscillations are thought to be mediated primarily by recip-
rocal interactions between excitatory and inhibitory neurons
(E-I) or by reciprocal interactions within networks of inhibitory
neurons (I-I) (Bartos et al., 2007; Buzsa´ki and Wang, 2012).
Consistent with a crucial role for GABA, nonselective blockade
of all GABAA receptor isoforms dampens g oscillations (Hasen-
staub et al., 2005). Surprisingly, we observed the opposite effect
when we photo-antagonized specifically a1-containing GABAA
receptors: enhancement of g power (increase of 28% ± 10%,
n = 3, p < 0.05, Friedman test over episodes; Figures 8E
and 8F). Experiments on control mice infused with vehicle alone
showed no significant change in g power (increase of 2% ± 1%,
n = 4, p > 0.05, Friedman test over episodes; Figures 8E and 8F).
Inhibitory synapses between PV cells (I-I connections) are
highly enriched with a1-containing receptors (Klausberger
et al., 2002). Hence, our results support a crucial role of I-I in g
rhythmogenesis.
DISCUSSION
LiGABAR Brings Optogenetic Control to the Synapse
LiGABAR, like other optogenetic tools, enables precise and ac-
curatemanipulation of signals in the nervous system. But instead
of manipulating an exogenous conductance added to a neuron,
the signal being manipulated by LiGABAR is generated from
within, by an endogenous neurotransmitter receptor. This en-
ables interrogation of endogenous receptor function across
broad levels of neural organization, from the molecular and cell
biology of GABAA receptors in individual neurons to the systems
biology of GABAA receptors in brain regions.
In principle, an endogenous protein could be made light sen-
sitive by chemical modification with a synthetic photoswitch or
by protein engineering with a light-sensitive module (e.g., the
LOV domain; Gautier et al., 2014). In practice, only the chemical
approach has been applied successfully to neurotransmitter re-
ceptors (Gautier et al., 2014; Kramer et al., 2013). Chemical
photosensitization requires only a single amino acid substitution,
allowing a receptor to retain its normal expression, trafficking,
and activity. In contrast, light-sensitive domains are large (e.g.,
>100 amino acids for LOV), and splicing a bulky domain into a re-
ceptor is likely to alter or disrupt its function. ChemicalNeuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 887
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Figure 8. In Vivo Photo-Control of Visually
Evoked Responses and g Oscillations in
the Awake a1-GABAA PhoRM Mouse
(A) Schematic illustration of the experimental pro-
cedures.
(B) Top: a neuronwith an increased firing rate when
a1-LiGABAR was antagonized (green points),
compared to its firing rate when a1-LiGABAR was
relieved from antagonism (violet points). Bottom: a
neuron with a decreased firing rate when a1-Li-
GABAR was antagonized.
(C) Average firing rates from (A) and (B) in each
illumination condition (20 episodes per condition).
(D) Summary of all of the cells recorded in PTL-
treated (PTL) and vehicle-treated (Ctrl) a1-GABAA
PhoRM mice. The number of cells that have sig-
nificant photoswitching in firing rate is shown in
blue for the PTL group and in red for the Ctrl group.
See Figure S7 for the classification of FS (fast-
spiking) and RS (regular spiking) cells.
(E) Example power spectrum of local field potential
in one of the PTL-treated a1-GABAA PhoRMmice.
Photo-antagonizing a1-LiGABAR in vivo (green)
increased the power of visually evoked g oscilla-
tions, compared to the g power when antagonism
was relieved (violet).
(F) Example recording of g power (averaged be-
tween 20 and 60 Hz) in episodes when a1-LiGA-
BAR was antagonized (green points) and in those
when the receptor was relieved from antagonism
(violet points). Data are presented as mean ± SEM.modification, in this regard, may be the only feasible way to
confer light sensitivity onto an endogenous neurotransmitter
receptor.
Our results show that conjugating a PTL onto a modified
GABAA receptor occurs quickly and efficiently in the brain under
physiological conditions. The PTL can be applied either on the
exposed surface of the brain or infused into neural tissue. In prin-
ciple, both the compound and the light can be delivered to any
part of the brain with an optrode containing both a capillary
and an optic fiber (Berglind et al., 2014).
At the cellular level, LiGABARs can be used to dissect the
functions of different GABAA isoforms within a neuron. Indepen-
dent photo-control offers a way to compare the geographical
distribution, synaptic versus extrasynaptic localization, and
functional impact of different isoforms. For example, our uncag-
ing results (Figure 2) suggest that the a1 isoform is concentrated
at synapses whereas a5 is broadly distributed, consistent with
prior observations by immunolabeling (Bru¨nig et al., 2002; Kasu-
gai et al., 2010).
At the network level, LiGABAR can help reveal the functional
impact of inhibition in a neural circuit. For example, GABAA re-888 Neuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc.ceptors mediate both presynaptic and
postsynaptic inhibition (Kullmann et al.,
2005; Farrant and Nusser, 2005), but un-
raveling these processes can be difficult.
Presynaptic inhibition can be detected
by measuring a decrease in neurotrans-
mitter release, but there is no surefireway to selectively manipulate presynaptic GABAA receptors
without also affecting postsynaptic GABAA receptors. By genet-
ically targeting LiGABAR to the presynaptic cell, photo-control
can be exerted selectively, elucidating the impact of different
forms of inhibition on circuit function and behavior.
At the organism level, the a1-GABAA PhoRMmouse offers the
unique opportunity to reversibly and specifically photo-antago-
nize an endogenous neurotransmitter receptor in vivo, revealing
its role in neural information processing and behavior. In princi-
ple, the same optical manipulation can be carried out with
knockin mice for all of the other isoforms, elucidating their indi-
vidual functions both in the normal brain and in neurological dis-
eases. Because of their absolute subtype specificity in receptor
photo-control, GABAA PhoRMmicemay also be useful for target
validation in drug discovery.
Practical Considerations
Specificity
Control of LiGABAR is sufficiently specific, fast, and powerful to
enable broad applications in neuroscience. Although some
membrane proteins have free extracellular cysteines that could
possibly be decorated by the PTL, we have detected no
off-target electrophysiological effects on wild-type GABA re-
ceptors, glutamate receptors, or voltage-gated ion channels
(Figure S3). Additional control experiments may be warranted
for new applications of LiGABAR to rule out unintended
consequences.
Light Requirements
We have shown that a1-LiGABAR can be photo-controlled
within 100 ms with an LED light source of 5-mW/mm2 intensity
(Figure 4). Brighter light could result in even faster photoswitch-
ing, as suggested by studies on light-gated glutamate receptors
(Reiner and Isacoff, 2014). The optimal wavelengths for azoben-
zene photoswitching are 360–400 nm for trans-to-cis and 460–
560 nm for cis-to-trans isomerization, but the action spectra
may be tuned via structural modifications on the azobenzene
core (Izquierdo-Serra et al., 2014). Once switched to the cis
state, the thermal stability of the PTL ensures that LiGABAR re-
mains lodged in that state for >10min in darkness (Figure 4). Brief
intermittent flashes of 380-nm light (e.g., 200 ms at 1/min) can
keep the PTL in the cis state indefinitely. For a trans-antagonist
this is an important feature, because it ensures relief of antago-
nism in darkness until the onset of 500-nm light. For a2–a6, we
have developed cis-antagonists such that the receptors operate
normally in darkness and are antagonized only when exposed to
380-nm light.
Limitations to Photo-Control
Photo-antagonism of LiGABAR is strong, but it can never be
absolutely complete even with saturating light. Several factors
may contribute to incomplete photoswitching. Conjugation of
the PTLmight be incomplete, leaving some receptors insensitive
to light. Alternatively, antagonismmay be limited by the affinity of
the PTL for the GABA-binding site. Thus, a high concentration of
GABA during synaptic transmission (Auger et al., 1998) might
transiently outcompete the PTL. Moreover, most neurons ex-
press multiple a isoforms of GABAA receptors, and only recep-
tors incorporating the mutant isoform will be subject to
photoswitching.
Gene Delivery
The gene of a mutant a subunit can be overexpressed in a
neuron, for example with a viral vector, or substituted for the
wild-type gene, for example in a knockinmouse. Viral expression
can be directed to a specified cell type with a customized vector,
whereas gene substitution will occur in all cell types in the
knockin mouse. If the experimental goal is to understand the
physiological or behavioral function of a given a isoform, then
the knockin mouse is preferable for preserving the normal
expression profile. If the goal is to understand the function of
an inhibitory connection in a neural circuit, then viral overexpres-
sion may be preferable for restricting photo-control to a partic-
ular locus in the circuit. Users will need to weigh the benefit of
achieving cell-specific expression against the uncertainty of
overexpression, which might alter the natural level or distribution
of GABAA receptors. The CRISPR (clustered regularly inter-
spaced short palindromic repeat)/Cas9 system allows gene sub-
stitution in terminally differentiated cells in vivo (Platt et al., 2014),
and we look forward to the time when exact genomic substitu-
tion of any a subunit can be achieved in an adult animal in a
cell-type-specific manner.EXPERIMENTAL PROCEDURES
The photoswitch compounds were synthesized as trifluoroacetate salts. The
compounds were prepared as concentrated stocks (10–100 mM in anhydrous
DMSO) and diluted in buffers for receptor conjugation (final DMSO concentra-
tion <1% v/v). AAV9 (1012 to 1013 vg/ml; viral genomes/ml) encoding a mutant
a subunit (a1T125C or a5E125C), an eGFP marker, and a human synapsin-1
promoter was prepared by the UC Berkeley Gene Delivery Module following
previously published procedures (Lin et al., 2014). The a1-GABAA PhoRM
mice were generated by the UC Davis Mouse Biology program. All experi-
ments were performed in accordance with the guidelines and regulations of
the Animal Care and Use Committee at the University of California, Berkeley.
Group data are reported as mean ± SEM. Detailed experimental procedures
and data analysis methods are available in Supplemental Experimental
Procedures.
Mutant Expression and PTL Treatment
Ex Vivo Procedures: HEK Cells, Cultured Neurons, and Brain Slices
HEK cells and dissociated hippocampal neurons were cultured on poly-L-
lysine-coated coverslips, maintained at 37C and 5% CO2, and transfected
via calcium phosphate precipitation. The mutant subunits were expressed in
organotypic hippocampal slices by injecting AAV9 encoding eGFP-2A-
a1T125C or eGFP-2A-a5E125C in the CA1 pyramidal cell body layer. Viral
transduction of mouse cerebral cortex was performed by neonatal injection
(Figures 3 and 4) or stereotactic injection in adult mice (Figures 5 and 6).
Prior to electrophysiological experiments, the cells or slices were treated
with Tris(2-carboxyethyl)phosphine (TCEP; 2.5–5 mM, 5–10 min), washed,
and then treated with PTL (25–50 mM, 25–45 min) at room temperature to
convert the mutant receptors into LiGABARs.
In Vivo PTL Treatment
For the experiments in Figures 5 and 6, we made a craniotomy of 2–3 mm in
diameter with subsequent duratomy on anesthetized mice. We applied
100 ml of HEPES-aCSF, which contained PAG-1C (250 mM) and TCEP
(250–500 mM), onto the exposed cortex for 1 hr. For multielectrode record-
ings in awake mice (Figure 8), we thinned the skull and opened a small
craniotomy (0.5–1.5 mm in diameter) without duratomy over the visual cor-
tex. The PTL solution was infused into the brain at a rate of 100 nl/min for
10 min with a glass micropipette attached to a microinfusion pump (UMP3
with SYS-Micro4 controller; World Precision Instruments). In control exper-
iments, vehicle solution containing 500 mM TCEP without PAG-1C was
infused.
Subcellular LiGABAR Mapping via Two-Photon GABA Uncaging
Imaging and uncaging were performed using a two-photon laser-scanning mi-
croscope (MOM; Sutter). The light source for fluorescence excitation (800 nm
for Alexa Fluor 594 and 940 nm for gephyrin intrabody) and RuBi-GABA uncag-
ing (800 nm) was a Ti:sapphire laser (Chameleon XR; Coherent). LiGABAR-ex-
pressing hippocampal neurons were voltage clamped at 0 mV, with 25 mM
DNQX (6,7-dinitroquinoxaline-2,3-dione), 50 mM D-AP5 [D-()-2-amino-5-
phosphonopentanoic acid], and 0.5 mM TTX (tetrodotoxin) in the bath. The
internal solution included 200 mM Alexa Fluor 594 (Life Technologies) for visu-
alizing dendritic morphology. RuBi-GABA (200–400 mM; Abcam) was added to
aCSF and recirculated using a peristaltic pump (Idex). Uncaging was carried
out at designated locations for 5–10 ms with a light intensity of 150 mW.
Full-field 390-nm (1.2mW/mm2) or 540-nm (3.2mW/mm2) conditioning flashes
(5 s) from an LED light source (Lumencor) were delivered through the objective.
Photoswitching was calculated as 1  (I540/I390), where I refers to the peak
amplitude of GABA-elicited current.
Photo-Control of LiGABAR In Vivo
Visual stimulus generated with Psychtoolbox (http://psychtoolbox.org) was
either a circular patch of drifting square-wave gratings in full contrast (Figure 6)
or a square full-contrast checkerboard (Figure 8) against a mean luminance
gray background. Targeted loose-patch recordings for Figure 6 were made
from PV-tdTOM and LiGABAR-eGFP double positive cells in layer 2/3 (150–
350 mm below pia) of the visual cortex, using a two-photon laser-scanning mi-
croscope (Sutter) with a Ti:sapphire laser (1,050 nm; Coherent). Data wereNeuron 88, 879–891, December 2, 2015 ª2015 Elsevier Inc. 889
filtered at 2 kHz and digitized at 20 kHz using a BNC-2090 analog-to-digital
convertor (National Instruments). For multielectrode extracellular recordings
(Figure 8), a 16-channel probe (A1x16-3mm-25-177-A16; NeuroNexus) was
used. Recordings were amplified and digitized at 30 kHz (SpikeGadgets).
MClust (http://redishlab.neuroscience.umn.edu/MClust/MClust.html) was
used for offline sorting of the spike waveforms.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2015.10.026.
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